Picture of Sopharma Trading AD logo

SFT Sopharma Trading AD Cashflow Statement

0.000.00%
bg flag iconLast trade - 00:00
HealthcareBalancedSmall CapNeutral

Annual cashflow statement for Sopharma Trading AD, fiscal year end - December 31st, BGN millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Changes in Working Capital-46.5-57.5-82.2-82.5-93.3
Other Operating Cash Flow
Cash from Operating Activities-182-217-17318.648
Capital Expenditures-20.6-11.1-12.8-9.23-14.8
Purchase of Fixed Assets
Other Investing Cash Flow Items-2.931.14-1.51-2.92-11
Sale of Fixed Assets
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-23.6-9.99-14.3-12.1-25.8
Financing Cash Flow Items20024319330.50.331
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities208227192-11.3-15.9
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash2.11-0.2454.42-4.866.28